2014•European NeuropsychopharmacologyRequires access

Chlorpromazine versus every other antipsychotic for schizophrenia: A systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs

Myrto Samara, Haoyin Cao, Bartosz Helfer, John M. Davis, Stefan Leucht

Open publisher page 31 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 31 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Antipsychotic, Olanzapine, Chlorpromazine, Clozapine, Schizophrenia (object-oriented programming), Psychiatry, Medicine, Meta-analysis

Back to paper search Browse research topics Original source

Chlorpromazine versus every other antipsychotic for schizophrenia: A systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs — Research Paper | ScholarLens